CohBar IncOver The Counter Market:CWBR
- LAST PRICE0.4900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.4900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CWBR |
|---|---|---|
| 01:00 ET | 15656 | 0.49 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CohBar Inc | 1.5M | -0.1x | --- |
Kiromic Biopharma Inc | 1.5M | 0.0x | --- |
Panbela Therapeutics Inc | 1.6M | 0.0x | --- |
GlucoTrack Inc | 1.4M | -0.1x | --- |
Pharmagreen Biotech Inc | 1.1M | -2.6x | --- |
Bluejay Diagnostics Inc | 1.9M | 0.0x | --- |
Company Information
CohBar, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting chronic and age-related diseases. Its processes of identifying nucleic acid sequences encoding native peptides in the mitochondrial genome, developing and optimizing novel analogs of these natural mitochondrial derived peptides (MDPs) and developing and conducting screens to identify and characterize the activities of these are referred to as its technology platform. Its advanced clinical candidate, CB4211, is a therapeutic for the treatment of nonalcoholic steatohepatitis and obesity. CB4211 demonstrated positive effects on reducing biomarkers of liver injury and improving metabolic homeostasis in a Phase 1a/1b clinical study in obese subjects with nonalcoholic fatty liver disease. CB4211 is a novel and improved analog of MOTS-c, a naturally occurring MDP. CB5138 Analogs are therapeutics that have demonstrated anti-fibrotic properties in a variety of preclinical models.
Contact Information
- Headquarters
- 1455 Adams Drive, Suite 1308MENLO PARK, CA, United States 94025
- Phone
- 650-446-7888
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 2.9M |
CohBar Inc does not pay a dividend. | |
Beta | 1.39 |
EPS | $-4.36 |
Book Value | $5.27 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
